Literature DB >> 6167687

HLA-antigens and the prognosis of multiple sclerosis.

S Poser, G Ritter, H J Bauer, H Grosse-Wilde, E K Kuwert, N E Raun.   

Abstract

The histocompatibility pattern of 160 patients with multiple sclerosis (MS) living in the epidemiological area of Southern Lower Saxony was determined and compared to a control population. The only significant difference was the more frequent occurrence of DW2 in the patient group (44% vs. 21%). Taking a progression index (grade of disability divided by the duration of the disease) as a measure for prognosis no difference could be found between the DW2 positive and the DW2 negative patients. The reason why we could not confirm the worse prognosis for DW2 positive patients found by Jersild et al. (1973) and Raun et al. (1980) remains to be investigated.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6167687     DOI: 10.1007/BF00313751

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  6 in total

1.  On the evaluation of disability in multiple sclerosis.

Authors:  J F KURTZKE
Journal:  Neurology       Date:  1961-08       Impact factor: 9.910

2.  Histocompatibility determinants in multiple sclerosis, with special reference to clinical course.

Authors:  C Jersild; T Fog; G S Hansen; M Thomsen; A Svejgaard; B Dupont
Journal:  Lancet       Date:  1973-12-01       Impact factor: 79.321

3.  Multiple sclerosis: association with HL-A3.

Authors:  S Naito; N Namerow; M R Mickey; P I Terasaki
Journal:  Tissue Antigens       Date:  1972

4.  Genetical aspects of multiple sclerosis with special regard to histocompatibility determinants.

Authors:  E K Kuwert
Journal:  Acta Neurol Scand Suppl       Date:  1977

5.  [Histocompatibility patterns in multiple sclerosis. Findings of an epidemiological study (author's transl)].

Authors:  S Poser; G Ritter; H J Bauer; E K Kuwert; P G Höher; H Grosse-Wilde; E Hierholzer
Journal:  Nervenarzt       Date:  1981-06       Impact factor: 1.214

6.  Genetic basis of multiple sclerosis: HLA antigens, disease progression, and oligoclonal IgG in CSF.

Authors:  L Stendahl-Brodin; H Link; E Möller; E Norrby
Journal:  Acta Neurol Scand       Date:  1979-06       Impact factor: 3.209

  6 in total
  6 in total

1.  HLA and prognosis in multiple sclerosis.

Authors:  B Runmarker; T Martinsson; J Wahlström; O Andersen
Journal:  J Neurol       Date:  1994-05       Impact factor: 4.849

2.  Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis.

Authors:  M Axelsson; C Malmeström; S Nilsson; S Haghighi; L Rosengren; J Lycke
Journal:  J Neurol       Date:  2011-01-01       Impact factor: 4.849

3.  Expression of the human histocompatibility leukocyte antigen DR3 transgene reduces the severity of demyelination in a murine model of multiple sclerosis.

Authors:  K M Drescher; L T Nguyen; V Taneja; M J Coenen; J L Leibowitz; G Strauss; G J Hammerling; C S David; M Rodriguez
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

4.  Genetic and infectious profiles of Japanese multiple sclerosis patients.

Authors:  Satoshi Yoshimura; Noriko Isobe; Tomomi Yonekawa; Takuya Matsushita; Katsuhisa Masaki; Shinya Sato; Yuji Kawano; Ken Yamamoto; Jun-ichi Kira
Journal:  PLoS One       Date:  2012-11-09       Impact factor: 3.240

5.  Peripheral blood T cell dynamics predict relapse in multiple sclerosis patients on fingolimod.

Authors:  Zi-Ye Song; Ryo Yamasaki; Yuji Kawano; Shinya Sato; Katsuhisa Masaki; Satoshi Yoshimura; Dai Matsuse; Hiroyuki Murai; Takuya Matsushita; Jun-ichi Kira
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

6.  Genetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patients.

Authors:  Satoshi Yoshimura; Noriko Isobe; Takuya Matsushita; Katsuhisa Masaki; Shinya Sato; Yuji Kawano; Hirofumi Ochi; Jun-Ichi Kira
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.